Introduction: The SARS-CoV-2 virus has evolved to mimic an enzyme, KAT2A (lysine acetyltransferase 2A, GCN5), one of the histone proteins that package DNA in the cell nucleus. Gene transcription is deranged because of this mimicry, which reduces antiviral response. An amino acid sequence known as the ARKS motif in histone H3 is modified by KAT2A, which adds acetyl groups and encourages gene transcription. The Orf8 protein from the SARS-CoV-2 virus also has an ARKS motif. KAT2A interacts with Orf8 via ARKS, which modifies it and may cause KAT2A destruction. Using structures from RCSB Protein Data Bank, we examined another way that Orf8 may interfere with KAT2A.
Methods: We analyzed two RCSB Protein Data Bank molecules: 1) 1Z4R. Human GCN5 (KAT2A) Histone Acetyltransferase. 2) 7F5F. SARS-CoV-2 Orf8 S84 viral protein. The protein structures were superimposed and aligned on PYMOL v 2.5.0 with the Super command, which super aligns two protein selections.
Results: Pymol performed 5 cycles of calculations on 65 aligned atoms of Human KAT2A (GCN5 Histone Acetyltransferase) and SARS-CoV-2 Orf8 S84 viral proteins, with a final root mean square deviation of atomic positions (RMSD) of 0.975 Angstrom for 51 atoms. Lower values of RMSD indicate that alignment is validated with higher accuracy. RMSD values of 1 Angstrom or less indicate very good alignment.
Conclusion: the 51 amino acid alignment of Human KAT2A Histone Acetyltransferase and SARS-CoV-2 Orf8 S84 viral protein we identified suggests a significant effect of Orf8 on KAT2A. Orf8 may interfere with KAT2A gene transcription and disrupt host cell ability to regulate gene expression and respond to SARS-CoV-2 infection effectively. Since transcription and translation are upregulated in cancer cells, Orf8 could also be a cancer treatment.